Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Gille

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Brain Research|August 26, 2004
Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamateKhaled Radad, Gabriele Gille, Rudolf Moldzio, et al.
Neurochemistry International|October 5, 2007
9-Methyl-beta-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic cultureJuliane Hamann, Catrin Wernicke, Jochen Lehmann, et al.
CNS & Neurological Disorders Drug Targets|August 5, 2016
Comparable Neuroprotective Effects of Pergolide and Pramipexole on Ferrous Sulfate-Induced Dopaminergic Cell Death in Cell CultureDoreen Reichelt, Khaled Radad, Rudolf Moldzio, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 15, 2020
9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytesSebastian Keller, Witold Henryk Polanski, Christoph Enzensperger, et al.
European Journal of Pharmacology|December 25, 2013
Rotigotine protects against glutamate toxicity in primary dopaminergic cell cultureSandra Oster, Khaled Radad, Dieter Scheller, et al.
Journal of Neurochemistry|March 3, 2012
9-Methyl-β-carboline-induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferationMichael Gruss, Dorothea Appenroth, Armin Flubacher, et al.
Journal of Neurology|May 12, 2011
Basic science in Parkinson's disease: its impact on clinical practiceJörg B Schulz, Manfred Gerlach, Gabriele Gille, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|May 14, 2003
Cytotoxic effects of packable and nonpackable dental compositesAlexander Franz, Franz König, Margit Anglmayer, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|May 15, 2016
Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson's diseaseMike Arnhold, Yanina Dening, Michaël Chopin, et al.
Plos One|January 26, 2010
Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in miceFrancisco Pan-Montojo, Oleg Anichtchik, Yanina Dening, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Brain Research|August 26, 2004
Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamateKhaled Radad, Gabriele Gille, Rudolf Moldzio, et al.
Neurochemistry International|October 5, 2007
9-Methyl-beta-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic cultureJuliane Hamann, Catrin Wernicke, Jochen Lehmann, et al.
CNS & Neurological Disorders Drug Targets|August 5, 2016
Comparable Neuroprotective Effects of Pergolide and Pramipexole on Ferrous Sulfate-Induced Dopaminergic Cell Death in Cell CultureDoreen Reichelt, Khaled Radad, Rudolf Moldzio, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 15, 2020
9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytesSebastian Keller, Witold Henryk Polanski, Christoph Enzensperger, et al.
European Journal of Pharmacology|December 25, 2013
Rotigotine protects against glutamate toxicity in primary dopaminergic cell cultureSandra Oster, Khaled Radad, Dieter Scheller, et al.
Journal of Neurochemistry|March 3, 2012
9-Methyl-β-carboline-induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferationMichael Gruss, Dorothea Appenroth, Armin Flubacher, et al.
Journal of Neurology|May 12, 2011
Basic science in Parkinson's disease: its impact on clinical practiceJörg B Schulz, Manfred Gerlach, Gabriele Gille, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|May 14, 2003
Cytotoxic effects of packable and nonpackable dental compositesAlexander Franz, Franz König, Margit Anglmayer, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|May 15, 2016
Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson's diseaseMike Arnhold, Yanina Dening, Michaël Chopin, et al.
Plos One|January 26, 2010
Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in miceFrancisco Pan-Montojo, Oleg Anichtchik, Yanina Dening, et al.
Pageof 3